If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Total mystery. I think a buying opportunity
...why the stock is down by 10% today. I cannot find any news at all.
Can anyone explain the sudden surge of interest. Buy \ Sell ratio looks healthy
Oh no !!! Results stink . Down the park again .
Is this finally heading north ??
Devro: Investec takes target price from 343p to 282p, while staying with its buy recommendation.
Panmure Gordon has downgraded its rating for sausage skins maker Devro from 'buy' to 'hold' on the back of 'deteriorating volume visibility' after a gloomy outlook from the firm. "Despite full-year 2013 results being in line with our expectations the company has provided a disappointing outlook statement citing poor volume visibility in developed markets and increased FX headwinds in 2014," said analysts Damian McNeela and Graham Jones. "As such we are lowering our earnings per share (EPS) forecasts by 12% and 8% in 2014E and 2015E respectively." These reductions would equate to a 5% fall in adjusted pre-tax profit this year to £38.7m and a 5.5% decline in EPS to 19.4p. McNeela and Jones said that they remain attracted over the medium-to-long-term to the macro drivers of rising per capita meat consumption and believe that Devro is well placed to "capitalise" on this growth. Even so, given the lack of near-term visibility in developed markets and the magnitude of the downgrades they cut their recommendation on the shares to 'buy' from 'hold'. The 350p target price for the stock was maintained.
EPS and dividend up. Why do we have a 9% drop?
Devro schedules trading update Devro, one of the world's leading manufacturers of collagen products for the food industry, will be announcing its third quarter interim management statement on 14 November. This will be followed by a capital markets event, held in the afternoon at the offices of Buchanan, 107 Cheapside, EC2V 6DN. At 9:50am: (LON:DVO) Devro share price was -0.35p at 308.85p Story provided by StockMarketWire.com
and 229k following it.....
big trade...
I am a firm believer in this share and i think it has great potential. It keeps increasing sales, but this year the profits were hit by input costs. I hope they can keep this under control and that "raising their prices" wont affect sales growth to a detriment. Still the best in their market and leading the way in terms of dividends i believe. http://www.business7.co.uk/business-news/company-results-and-forecasts/2013/02/26/devro-profits-hit-by-rising-input-costs-106408-23961494/
Devro: Societe Generale raises target price from 380p to 410p.
CAN,T see this share staying at these low prices.......imo Too good a firm with excellent prospects ..........Topped -up today......... GOOD LUCK
Steve Hannam, the Chairman of FTSE 250 sausage casing supplier Devro, has added to 12,594 shares to his and his wife's stake in the company on the same day the company warned that full-year operating profits will be slightly below expectations, although still ahead of last year. Hannam purchased the shares at 317.61p each for a total of £40,000. He and his wife now hold 223,622 shares, equal to 0.135% of the issued share capital. The firm blamed the decrease in expected profits on a number of factors, namely adverse currency movements, increased raw material costs and extended plant commissioning periods. It said it expects the trend of increased raw material prices to continue into next year. Consensus forecasts for the full year ending December 31st are for pre-tax profits of £43.64m on turnover of £242.50m. Earnings per share are expected to come in at 21.15p, putting it on a price earnings ratio of 15.9. In an interim management statement covering the period from July 1st to date, the firm was upbeat about turnover, saying: "Sales volumes have continued to grow across a wide range of markets, notably in Japan, Europe and the Americas, with sales of the premium 'Select' range continuing the momentum of the first half. Overall market demand remains strong both in established and emerging markets."
Devro: Panmure Gordon keeps hold rating and 320p target; Investec keeps buy rating and 355p target.
The interim dividend was increased from 2.5p to 2.65p. As expected, following the firm's investment programme, net debt increased to £31.4m (2011: £24.0m). Regionally, edible collagen volumes in continental Europe continue to increase, particularly in Eastern Europe, Scandinavia and Germany with sales of Select making a significant contribution to this increase. The Eurozone difficulties have had limited impact on the levels of demand and sales. UK and Ireland volumes, as expected, were down as a small number of product lines moved back to hog gut casing. Edible collagen volumes in the Americas increased considerably with solid growth in Latin American markets. Strong manufacturing performance compared to the prior year assisted in the improved availability of product to satisfy demand. Total volumes were up in Asia/Pacific with Japan showing significant growth reflecting the demand for Select. South East Asia and Korea also continue to grow.
Devro, a manufacturer of collagen products for the food industry, is on track to meet its full year targets following continued strong sales growth in Japan, South East Asia, Eastern Europe and Latin America. Revenue for the half-year increased 7.7% to £115.4m (2011: £107.1m), with operating profit of £20.7m (2011: £19.5m), despite higher input costs. Profit before tax, excluding net finance expense/income on pension, was £20.2m, 5.7% higher than £19.1m the same half the previous year, with earnings per share at 9.9p (2011: 9.2p). Reported profit before tax was unchanged at £19.6m. Steve Hannam, Chairman of Devro, said: "Sales have increased across a wide range of markets and the good momentum from the second half of 2011 has continued into 2012. "Sales of our premium Select range, which is specifically designed to replicate the characteristics of high quality sheep gut in developed markets, continue to grow strongly in Japan and Europe, and we are now achieving our 2012 target for Select of 8% of total sales. "The global market for collagen casings continues to expand due to economic growth and increased meat consumption in emerging markets. High sheep gut prices and limited availability also provide good opportunities in developed markets for substitution by collagen casing. "The outlook for the remainder of the year is for continued volume growth particularly of sales of differentiated products such as Select, supported by further manufacturing improvements arising from our capital program
Investec Securities retained its "buy" stance on Devro (DVO) with a 345p target price. The broker expects the sausage casings manufacturer to report first half pre-tax profit growth of 5% to 20 million pounds and believes the firm's primary focus will be the installation of new capacity to support future growth. Investec noted growing demand for the group's products in emerging markets, while adding that its Select brand is selling at a premium in mature markets. Devro shares lost 5.2p to 309.5p.
Growing Chinese Demand Helps Devro Exports To Surge SAUSAGE skin maker Devro unveiled a rise in sales during the first quarter, as export growth made up for a slow start to the year in its domestic market. Steve Hannam, chairman of the Moodiesburn-based firm, told investors at its annual general meeting that eastern Europe, Japan, Latin America, Russia and south-east Asia were “all demonstrating solid growth”. Hannam described trading conditions in the UK as “slow”, but added that sales of the company’s up-market “Select” range of collagen products – which replace sheep gut in premium sausages – had increased in Europe and Japan. He added: “Manufacturing performance was slightly below expectations early in the year, but recent performance is much improved. “The newly installed lines in Scotland are in full production and product development work continues on the new line in the US.” Replacing older machines at its factory in Bellshill helped Devro to post a 22.4 per cent rise in profits before exceptional items to £43 million in 2011, on the back of a 6.6 per cent increase in turnover to £227.7m. Devro, which employs more than 2,100 people, is also installing more efficient equipment at its facility in the Czech Republic. Chief executive Peter Page said: “The continued growth in volume and value of sales, across a wide variety of markets, is most encouraging and reflects well on our strategy for long-term growth.” Devro and its peers have enjoyed rising sales in China and other developing markets in south-east Asia as the growing middle-classes spend more money on processed meat. The firm sells cases made from collagen, the same material that makes up the connective tissue found in all mammals, which is designed to replace sausage skins made from animal guts. See also Herald's article: http://www.heraldscotland.com/business/company-news/sausage-maker-devro-sees-tasty-gains-from-casings.17355852 P.S. Here's a couple of links about SCLP, one of the hottest stocks at the moment: http://www.euroinvestor.com/community/discussionthread.aspx?threadid=252803 http://www.euroinvestor.com/community/discussionthread.aspx?threadid=253089
Shore Capital maintained its "buy" stance on Devro (DVO) following strong full year results, with adjusted pre-tax profit growth of 22.4% to 43 million pounds, on revenues of 27.7 million pounds. The broker believes that the sausage skin manufacturer will be able to improve its margins through modernising its production systems, brand development and economies of scale
In the Telegraph Questor's column is all about sausage skin maker Devro, which uses collagen to encase the meat instead of the more traditional gut. After stripping out exceptional items profits rose 22.4% in 2011 with the shares trading at 14.6 2012 earnings. Questor loves Devro but thinks after a surge of 21% so far this year, it’s time to sell.
http://www.investegate.co.uk/Article.aspx?id=201202210700087698X Very happy with my investment in Devro , dividend up. Hopefuuly the market will like the results.
Big day on Tuesday - expecting another good set of result and further upward trend to this core isa holding...
Societe Generale initiates sell on Devro, target price 215p